Abbott India Share Price

Q: What is Abbott India share price today?

Abbott India share price is ₹25,895.00 as on 03 Jul, 2026, 15:41 IST.

Q: How has the Abbott India share price performed in the past?

In the last 1 year, Abbott India delivered a return of -26.89%. The Abbott India share price hit a high of ₹35,310.00 and low of ₹25,150.00.

Q: How much is the Mutual Fund shareholding in Abbott India shares?

The Mutual Fund Shareholding in Abbott India was 7.68% at the end of Mar 2026.

Q: What is the the 52-week high and low of Abbott India shares ?

The 52-week high and low of Abbott India share is ₹35,310.00 and ₹25,150.00 as of 03 Jul, 2026.

Q: What is the market cap of Abbott India?

The market capitalisation of Abbott India is ₹464.94 Crores as on 03 Jul, 2026.

Q: What are the stock symbols of Abbott India?

The stock symbol of Abbott India is ABBOTINDIA on the NSE, 500488 on the BSE, and the ISIN is INE358A01014.

Q: What was yesterday's closing price of Abbott India shares ?

Abbott India shares closed yesterday at ₹25,725.00 on NSE & ₹25,721.65 on BSE

Q: How to buy Abbott India shares?

To buy Abbott India shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.

Q: Can I buy Abbott India shares on Holidays?

No, shares of Abbott India or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Abbott India shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

Q: What is the PE and PB ratio of Abbott India?

The PE and PB ratio of Abbott India is 35.22 and 11.45 respectively, as on 03 Jul, 2026, 15:41 IST.

NSE: ABBOTINDIA

Pharmaceuticals

₹ 25,895.00

+₹170.00 (0.66%)

Last updated 03 Jul, 2026, 15:41 IST

Abbott India Share Price Today

As of 5 Jul 2026, Abbott India share price is ₹25,895.00. The stock opened at ₹25,850.00, compared to its previous close of ₹25,725.00. During today's trading session, Abbott India share price moved in the range of ₹25,615.00 to ₹26,120.00, with an average price of ₹25,867.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹25,150.00 and a high of ₹35,310.00. On the performance front, Abbott India share price has declined by 7.93% over the last six months and is down 26.89% on a year-on-year basis.

₹25,615.00

0.66% up today

₹26,120.00

1D LOW

1D HIGH

Stock Performance

UnderperformingUnderperforming Nifty by 20.89 % in last 1 year

Shareholding Pattern

DIIDII decreased stake by 6.98%

Shareholding Pattern

FIIFII increased stake by 45.38%

Abbott India Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹3,72,751-₹1,27,249 (-25.45%)

3 Year

₹5,37,942+₹37,942 (+7.59%)

5 Year

₹6,80,990+₹1,80,990 (+36.20%)

Open

₹25,850.00

High

₹26,120.00

Low

₹25,615.00

Prev. close

₹25,725.00

₹20,720.00₹31,070.00

Circuit Low

Circuit High

₹25,150.00₹35,310.00

52-Week Low

52-Week High

Circuit

₹20,720.00

₹31,070.00

52-week

₹25,150.00

₹35,310.00

Abbott India Shareholder Returns

Abbott India Share Price History

Mkt Cap Cr

464.94

P/E

35.22

P/B

11.45

ROE

37.86%

D/E

0.04

ROCE

54.90%

Div. Yield

1.85%

EPS(TTM)

730.36

Turnover

1.38

EV/EBITDA

23.95

Net Margin

0.00%

Op. Margin

0.00%

ROA

33.03%

Quick Ratio

0.00

Curr. Ratio

2.62

Mkt Cap Cr

464.94

P/E

35.22

P/B

11.45

ROE

37.86%

D/E

0.04

ROCE

54.90%

Div. Yield

1.85%

EPS(TTM)

730.36

Turnover

1.38

EV/EBITDA

23.95

Net Margin

0.00%

Op. Margin

0.00%

ROA

33.03%

Quick Ratio

0.00

Curr. Ratio

2.62

Based on fundamentals, this stock's

Performance

Very Poor

Abbott India has not beaten FD return of 7%

Valuation

Fairly Valued

Abbott India appears to be fairly valued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,49,048.00	39.02	5.37	13.74%	0.61	17.33%	93.24	0.85%	0.56	10.90
Divis Laboratories	1,77,179.00	69.00	10.57	15.32%	0.00	19.56%	629.49	0.45%	0.58	98.19
Torrent Pharmaceuticals	1,57,804.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,17,642.00	25.47	2.87	11.79%	0.00	15.66%	2.89	1.06%	0.49	43.52
Dr. Reddy's Laboratories	1,12,368.00	27.03	2.97	11.07%	0.18	12.54%	375.78	0.59%	0.63	38.68
Zydus Lifesciences	1,10,651.00	21.60	4.08	18.59%	0.31	17.35%	235.25	0.09%	0.39	35.38
Lupin	1,09,676.00	20.48	4.89	23.76%	0.04	24.88%	659.05	0.75%	0.61	129.18
Mankind Pharma	1,02,729.00	53.00	6.30	11.74%	0.34	13.13%	397.02	0.04%	0.54	49.37
Aurobindo Pharma	90,608.00	25.87	2.39	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	82,398.90	60.26	10.10	18.21%	0.45	16.70%	10.19	0.20%	0.97	13.72

Abbott India Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹6,409.15	₹5,848.91	₹5,348.73	₹4,919.27
Other Income	₹275.58	₹248.27	₹154.15	₹77.21
Total Revenue	₹6,684.73	₹6,097.18	₹5,502.88	₹4,996.48
Total Expenses	₹4,797.78	₹4,479.43	₹4,229.06	₹3,916.75
Profit Before Tax	₹1,886.95	₹1,617.75	₹1,273.82	₹1,079.73
Tax	₹472.51	₹416.53	₹324.41	₹281.03
Profit After Tax	₹1,414.44	₹1,201.22	₹949.41	₹798.70
EPS - Basic	₹665.62	₹565.28	₹446.80	₹375.87
EPS - Diluted	₹665.62	₹565.28	₹446.80	₹375.87

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹1,886.95	₹1,617.75	₹1,273.82	₹1,079.73
Income before WC changes	₹1,722.32	₹1,487.90	₹1,211.12	₹1,107.71
Change in Assets	-₹310.61	₹18.74	₹27.19	-₹18.95
Change in Liabilities	₹47.19	₹110.64	-₹4.06	₹147.89
Change in WC	-₹263.42	₹129.38	₹23.13	₹128.94
Cash flow from Operations	₹1,011.84	₹1,212.81	₹893.39	₹947.66
Cash flow from Investing	₹182.18	-₹416.03	-₹147.71	-₹395.84
Cash flow from Financing	-₹925.17	-₹744.71	-₹638.72	-₹637.38
Total Cash Flow	₹268.85	₹52.07	₹106.96	-₹85.56
Cash (Start of the year)	₹291.74	₹239.67	₹132.71	₹218.27
Cash (End of the year)	₹560.59	₹291.74	₹239.67	₹132.71

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,175.72	₹1,947.65	₹1,530.40	₹371.08
Current Assets	₹4,741.59	₹3,245.84	₹3,025.11	₹3,853.04
Total Assets	₹5,917.31	₹5,193.49	₹4,555.51	₹4,224.12
Current Liabilities	₹1,407.19	₹1,342.72	₹1,206.02	₹1,203.19
Net Current Asset	₹3,334.40	₹1,903.12	₹1,819.09	₹2,649.85
Non-Current Liabilities	₹276.97	₹151.88	₹160.95	₹201.14
Equity Capital	₹4,233.15	₹3,698.89	₹3,188.54	₹2,819.79
Total Equity & Liabilities	₹5,917.31	₹5,193.49	₹4,555.51	₹4,224.12

* All values are in INR Crore

Qty

Bid

25895

Ask

Qty

Bid Total: 17

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bearish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

47.22

Neutral

ATR (14)

456.43

Neutral

STOCH(9,6)

53.88

Neutral

STOCH RSI (14)

100

Bearish

ADX(9)

27.93

Bearish

UO(9)

39.12

Neutral

ROC(12)

-0.79

Bearish

WillR(14)

-49.64

Neutral

Period

Simple value

Exponential vaue

25581

25701.82

10D

25693.5

25740.17

20D

25905.5

25936.9

50D

26350.3

26248.4

100D

26420.95

26652.54

About Abbott India

ISIN

INE358A01014

Sector Market Cap

₹ 464.94 Cr

Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.

Know more

Promoters

74.99%

FII

0.26%

Other DII

1.25%

Retail and other

15.81%

Mutual funds

7.68%

Foreign institutions - FII